课题基金 / 基金详情

项目摘要

项目成果

LINDA A SHERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NOD mice spontaneously develop Type 1 Diabetes (T1D) due to a loss of T cell tolerance to islet antigens. Congenic strains of NOD mice that are highly protected from the occurrence of T1D, because they have multiple resistance alleles situated on two chromosomes (ldd3/5 mice) or 3 linked resistance alleles on a single chromosome (Idd9), do not harbor high-avidity, islet-specific CDS T cells. In order to delineate the mechanism by which CDS tolerance is restored, we will trace the path of naive, islet-specific CDS cells in situations where resistance alleles at multiple or single Idd loci are expressed only in particular cell types. This will provide an assay that will identify the cell(s) that must express specific protective Idd genes to achieve CDS tolerance. We will then correlate gene expression of candidate Idd genes within the relevant cell populations obtained from NOD or congenic mice with the functional consequences that relate to protection from autoimmunity. Although four of the subregions, Idd3, Idd5.1, Idd5.2 and Idd9.3 are relatively well-characterized and the likely molecular basis of disease susceptibility is known in each case, Idd5.3, Idd9.2, and Idd9.1 require further efforts to positionally clone the Idd genes. Relevance: The occurrence of T1D in humans and mice has been mapped to a number of genetic susceptibility loci that prevent T cell tolerance to islet antigens. By elucidating naturally occurring mechanisms that restore such tolerance (as defined by Idd genes that prevent disease), we will better understand the etiology of the disease and also identify targets for interventions that can be used to prevent T1D.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.1203422
发表时间: 2013-04-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Lin X, Hamilton-Williams EE, Rainbow DB, Hunter KM, Dai YD, Cheung J, Peterson LB, Wicker LS, Sherman LA]
通讯作者: Sherman LA
Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
Idd9.1 位点控制 FoxP3 CD4 CD25 调节 T 细胞的抑制活性。
DOI: 10.2337/db09-0648
发表时间: 2010
期刊: Diabetes
影响因子: 7.7
作者: [Yamanouchi,Jun, Puertas,Maria-Carmen, Verdaguer,Joan, Lyons,PaulA, Rainbow,DanielB, Chamberlain,Giselle, Hunter,KaraM, Peterson,LaurenceB, Wicker,LindaS, Santamaria,Pere]
通讯作者: Santamaria,Pere
PTPN22 R619W in NOD mice
  • 批准号:
    10183146
  • 项目类别:
  • 资助金额:
    $74.52万
  • 财政年份:
    2017
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
PTPN22 R619W in NOD mice
  • 批准号:
    9307520
  • 项目类别:
  • 资助金额:
    $76.27万
  • 财政年份:
    2017
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
Creating Mouse Models to Study the Link Betwee PTPN22 and ACPA+ RA
  • 批准号:
    9300832
  • 项目类别:
  • 资助金额:
    $21.18万
  • 财政年份:
    2016
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
Mutant PTPN22 in autoimmune mice
  • 批准号:
    9095202
  • 项目类别:
  • 资助金额:
    $14.44万
  • 财政年份:
    2015
  • 负责人:
    LINDA A SHERMAN
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究